Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Interest Expenses (2020 - 2022)

Maxcyte (MXCT) has disclosed Interest Expenses for 3 consecutive years, with $11000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Interest Expenses changed N/A to $11000.0 in Q4 2022 year-over-year; TTM through Sep 2023 was $11000.0, a 90.52% decrease, with the full-year FY2022 number at $127000.0, down 87.84% from a year prior.
  • Interest Expenses was $11000.0 for Q4 2022 at Maxcyte, down from $116000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $742300.0 in Q1 2021 to a low of $11000.0 in Q4 2022.
  • A 3-year average of $230971.4 and a median of $164700.0 in 2020 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: plummeted 91.99% in 2021, then crashed 59.86% in 2022.
  • Maxcyte's Interest Expenses stood at $280600.0 in 2020, then grew by 2.99% to $289000.0 in 2021, then plummeted by 96.19% to $11000.0 in 2022.
  • Per Business Quant, the three most recent readings for MXCT's Interest Expenses are $11000.0 (Q4 2022), $116000.0 (Q3 2022), and $289000.0 (Q3 2021).